Header Logo

Connection

NAVAL DAVER to Hematinics

Back to Details
This is a "connection" page, showing publications NAVAL DAVER has written about Hematinics.
NAVAL DAVER
Connection Strength
0.402
Hematinics
  1. A phase II open-label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndrome. Eur J Cancer Care (Engl). 2013 Sep; 22(5):605-11.
    View in: PubMed
    Score: 0.402
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.